Qiming Venture Partners Welcomes Apollomics’ Successful IPO on Nasdaq
SHANGHAI, March 31, 2023 /PRNewswire/ — On March 30, 2023, Apollomics Inc. (“Apollomics”), an innovative biopharmaceutical company and portfolio company of Qiming Venture Partners, listed on...